Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RNA-plex is a non-specific name that refers to several distinct products and technologies in the life sciences and healthcare sectors. Primarily, it is used as a brand name for **multiplexed RNA diagnostic assays**, such as the **Zybio RNA-plex** and **Sansure RNA-plex** kits, which are RT-PCR-based in vitro diagnostic (IVD) tools designed for the simultaneous detection of respiratory pathogens including SARS-CoV-2, Influenza A, and Influenza B. In the therapeutic and wellness space, **RNA-Plex** is a **homeopathic combination remedy** (produced by companies such as **DesBio** and **Professional Formulas**) marketed for the temporary relief of symptoms associated with viral infections, such as fever and fatigue. Historically, the term was also utilized by **Sirnaomics** to describe its proprietary **Polypeptide Nanoparticle (PNP)** delivery platform, which employs histidine-lysine co-polymers (HKP) to encapsulate and deliver siRNA therapeutics to target tissues. Additionally, **RNAplex** is the name of a widely used bioinformatics software tool for predicting RNA-RNA interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RNA-plex.